ACTA is FDA-registered, DEA-licensed across Schedules I to V, and cGMP compliant, with a 35+ year FDA inspection history. Every credential, registration, and quality system is listed on this page.
ACTA has been inspected by the FDA since 1990 across new drug applications, abbreviated new drug applications, and general cGMP programs. The most recent inspection was in September 2026 and resulted in 2 minor observations.
ACTA operates under current Good Manufacturing Practice, 21 CFR Parts 210, 211, and 820. Analytical data is managed under 21 CFR Part 11 Computer Systems coupled with Good Documentation Practices, so every result is traceable and defensible.
Methods follow USP, BP, JP, CP, and EP compendia, or are developed at ACTA. Method Validation, Transfer, and Verification must be requested by ACTA's client and are required for full cGMP compliance. Controlled-substance work is handled under ACTA's DEA license across Schedules I to V. Every project closes with a concise cGMP Certificate of Analysis, with raw data available on request.
Our FDA registration, DEA license, and cGMP records are available on request. Reach out and we will send them.
Contact us